1. Sabih A, Leslie SW. Complicated Urinary Tract Infections Treasure Island (FL), 2023.
2. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. Complicated urinary tract infections: developing drugs for treatment. Guidance for industry. Revision 1. FDA. Available online: https://www.fda.gov/media/71313/download
3. Committee for Human Medicinal Products (CHMP). Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections, Rev. 3. (EMA/844951/2018 Rev. 3). European Medicines Agency. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-evaluation-medicinal-products-indicated-treatment-bacterial-infections-revision-3_en.pdf
4. Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The increase in hospitalizations for urinary tract infections and the Associated costs in the United States, 1998–2011. Open Forum Infect Dis. 2017;4:ofw281. https://doi.org/10.1093/ofid/ofw281.
5. Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Descriptive epidemiology and outcomes of hospitalizations with complicated urinary tract infections in the United States, 2018. Open Forum Infect Dis. 2022;9:ofab591. https://doi.org/10.1093/ofid/ofab591.